IL6 and Insulin resistance: I3S1DF significantly reduced the FBG level, improved the mice glucose tolerance, decreased insulin resistance and reduced the serum LDL-C, UA and IL-6 levels, indicating that I3S1DF can alleviate lipid metabolism abnormalities in obese mice.